BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25333257)

  • 1. Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein.
    Zheng H; Liu Z; Liu T; Cai Y; Wang Y; Lin S; Chen J; Wang J; Wang Z; Jiang B
    Oncotarget; 2014 Nov; 5(21):10763-77. PubMed ID: 25333257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.
    Zheng H; Li W; Wang Y; Liu Z; Cai Y; Xie T; Shi M; Wang Z; Jiang B
    Eur J Cancer; 2013 Aug; 49(12):2734-46. PubMed ID: 23582741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
    Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
    Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer.
    Zheng H; Li W; Wang Y; Xie T; Cai Y; Wang Z; Jiang B
    Carcinogenesis; 2014 Jan; 35(1):173-83. PubMed ID: 23929433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer.
    Zheng HX; Cai YD; Wang YD; Cui XB; Xie TT; Li WJ; Peng L; Zhang Y; Wang ZQ; Wang J; Jiang B
    Oncogene; 2013 Feb; 32(9):1183-92. PubMed ID: 22508480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
    Chen Y; Bieber MM; Teng NN
    Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
    Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
    J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
    Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
    Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
    Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
    Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of SFRP5 is related to multidrug resistance in leukemia cells.
    Wang H; Wang X; Hu R; Yang W; Liao A; Zhao C; Zhang J; Liu Z
    Cancer Gene Ther; 2014 Feb; 21(2):83-9. PubMed ID: 24434572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
    Lee YK; Lin TH; Chang CF; Lo YL
    PLoS One; 2013; 8(11):e82478. PubMed ID: 24303084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells.
    Guo X; Ma N; Wang J; Song J; Bu X; Cheng Y; Sun K; Xiong H; Jiang G; Zhang B; Wu M; Wei L
    BMC Cancer; 2008 Dec; 8():375. PubMed ID: 19091131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
    PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
    Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
    Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells.
    Kamioka H; Edaki K; Kasahara H; Tomono T; Yano K; Ogihara T
    J Pharm Pharmacol; 2021 Dec; 73(12):1609-1616. PubMed ID: 34313784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
    Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.